AI assistant
Sending…
Verastem, Inc. — Director's Dealing 2017
Oct 12, 2017
32713_dirs_2017-10-11_ad209665-87c5-4816-95fe-66e6ca868b19.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Verastem, Inc. (VSTM)
CIK: 0001526119
Period of Report: 2017-10-09
Reporting Person: Le NgocDiep T. MD, PhD (Chief Medical Officer)
More from Verastem, Inc.
Share Issue/Capital Change
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Director's Dealing
2026
Mar 23
Investor Presentation
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13